SUTRO BIOPHARMA, INC. (STRO) Operating income 2016–2025
SUTRO BIOPHARMA, INC. (STRO) annual operating income history from SEC filings — each fiscal year as reported.
-$158.4MFY2025 · since FY2016: $1.4M → -$158.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$158.4M | +33.6% |
| FY2024 | -$238.5M | -167.1% |
| FY2023 | -$89.3M | +30.8% |
| FY2022 | -$128.9M | -30.9% |
| FY2021 | -$98.5M | -38.7% |
| FY2020 | -$71.1M | -28.1% |
| FY2019 | -$55.5M | -49.0% |
| FY2018 | -$37.2M | -93.1% |
| FY2017 | -$19.3M | -1512.9% |
| FY2016 | $1.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice